14-day Premium Trial Subscription Sign Up For FreeGet Free

Agile Therapeutics Stock Forecast NASDAQ:AGRX

Price Target and Analyst Ratings

Most Recent Rating

On September 13, 2021 "HC Wainwright" gave "$7.00 - $3.50" rating for AGRX. The price target was changed from $1.17 to 6.4%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-13 $7.00 - $3.50 Target Lowered by HC Wainwright $1.09 $1.17→6.4%
2021-08-20 $4.00 Reiterated by Maxim Group $1.02 $1.02+0.0%
2021-07-27 $6.00 - $1.03 Reiterated by Royal Bank of Canada $1.11 $1.08→3.6%
2021-07-27 $6.00 - $5.00 Target Lowered by Royal Bank of Canada $1.11 $1.12→3.4%
2021-05-05 Buy Reiterated by Oppenheimer $1.51 $6.00
2020-12-08 Buy Reiterated by Oppenheimer $2.95 $10.00
2020-12-08 Buy Target Raised by HC Wainwright $2.95 $6.00 → $7.00
2020-11-16 Buy Reiterated by Royal Bank of Canada $2.93 $8.00
2020-11-13 Buy Reiterated by Oppenheimer $2.87 $12.00
2020-09-25 Buy Reiterated by William Blair $2.88
2020-09-09 Buy Reiterated by Maxim Group $3.16 $8.00

AGRX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -19.88% during the next 3 months and, with a 90% probability hold a price between $0.68 and $0.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $0.84 $1.02 $1.21
2021-09-23 $0.83 $1.02 $1.21
2021-09-24 $0.83 $1.02 $1.20
2021-09-27 $0.82 $1.01 $1.20
2021-09-28 $0.82 $1.01 $1.19
2021-09-29 $0.81 $1.00 $1.19
2021-09-30 $0.81 $1.00 $1.18
2021-10-01 $0.80 $0.99 $1.18
2021-10-04 $0.80 $0.99 $1.17
2021-10-05 $0.79 $0.98 $1.17
2021-10-06 $0.79 $0.98 $1.16
2021-10-07 $0.79 $0.97 $1.16
2021-10-08 $0.78 $0.97 $1.15
2021-10-11 $0.78 $0.96 $1.15
2021-10-12 $0.77 $0.96 $1.14
2021-10-13 $0.77 $0.95 $1.14
2021-10-14 $0.76 $0.95 $1.14
2021-10-15 $0.76 $0.94 $1.13
2021-10-18 $0.75 $0.94 $1.13
2021-10-19 $0.75 $0.93 $1.12
2021-10-20 $0.74 $0.93 $1.12
2021-10-21 $0.74 $0.92 $1.11
2021-10-22 $0.73 $0.92 $1.11
2021-10-25 $0.73 $0.91 $1.10
2021-10-26 $0.72 $0.91 $1.10
2021-10-27 $0.72 $0.90 $1.09
2021-10-28 $0.71 $0.90 $1.09
2021-10-29 $0.71 $0.90 $1.08
2021-11-01 $0.70 $0.89 $1.08
2021-11-02 $0.70 $0.89 $1.07

About Agile Therapeutics

Agile Therapeutics Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cyc... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT